Breast cancer affects more women in the United States than any other form of cancer. Upon diagnosis, many patients choose to fight back with chemotherapy—an aggressive, drug-based treatment that often includes Taxotere®, an injectable concentrate. Chemotherapy has well-documented side effects, such as nausea, fatigue, and temporary hair loss. However, some female cancer survivors are learning that Taxotere can cause permanent hair loss, or alopecia—a side effect they weren’t warned about.
If you or your mother, sister, or daughter were diagnosed with Stage 1,2, or 3 cancers after 2005 and suffered permanent alopecia following chemotherapy treatment, call our lawyers now. Our law firm knows how difficult it is to beat cancer, and we understand the frustration the self-esteem, body image, and quality of life issues caused by permanent hair loss. You’re not alone. Contact us online or by phone to get help now.
Research Links Taxotere® to Permanent Alopecia in Women
Cancer patients are warned of the side effects they can expect to face before undergoing chemotherapy. One of the most well-documented of these consequences is temporary hair loss. In most cases, patients are told they can expect complete hair regrowth 3-6 months after they complete their treatment. But since the mid-2000s, reports of permanent hair loss after chemotherapy treatment have increased.
A study published by Annals of Oncology analyzed 20 female breast cancer patients who suffered permanent alopecia after undergoing chemotherapy. Researchers concluded that taxane chemotherapy drugs like Taxotere “seem to be responsible for [severe and permanent female hair loss].” Nutritional deficiencies and hormonal imbalance, two factors linked to female hair loss, were ruled out as factors among the study’s participants.
Get Help With Your Taxotere® Lawsuit
Surviving breast cancer takes immeasurable courage and strength, and you deserve to know how the drugs you’ve been treated with can affect you. Our lawyers want to help if you or a loved one suffered permanent alopecia after chemotherapy treatment for Stage 1, 2, or 3 cancers after 2005. You may be entitled to compensation for what you’ve gone through, but there are strict time limits to file a claim. Call or contact us online now to get started.
Taxotere® is a registered trademark of sanofi-aventis U.S. LLC and is used here only to identify the product in question. This law firm is not associated with, sponsored by, or affiliated with Annals of Oncology, sanofi-aventis U.S. LLC, or the U.S. Food and Drug Administration.